Overview
New York, NY – Aug 25, 2025 – Global Oxygen Therapy Market size is expected to be worth around USD 62.3 Billion by 2032 from USD 39.1 Billion in 2024, growing at a CAGR of 6.1% during the forecast period from 2025 to 2032.
The global oxygen therapy market is experiencing steady growth, driven by the increasing prevalence of chronic respiratory conditions and the rising adoption of advanced medical devices. Oxygen therapy has become an essential treatment modality for patients suffering from chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and other respiratory disorders. The therapy provides patients with supplemental oxygen to maintain adequate oxygen levels, thereby improving survival rates, quality of life, and overall health outcomes.
The market expansion is further supported by the growing aging population, heightened awareness of respiratory health, and the rising burden of air pollution worldwide. In addition, the COVID-19 pandemic underscored the critical role of oxygen therapy in managing severe respiratory distress, leading to stronger investments in healthcare infrastructure and oxygen delivery systems.
Technological advancements, such as portable oxygen concentrators and home-based therapy solutions, are broadening patient accessibility and convenience. These innovations are enabling a shift from hospital-based treatments to home care settings, reducing healthcare costs while improving patient comfort and adherence.
The growth of the oxygen therapy market can be attributed to government initiatives, increased healthcare spending, and the presence of key industry players investing in research and development. With continuous innovation and rising demand, the market is expected to witness sustainable growth in the coming years.
Key Takeaways
- Market Growth: The global oxygen therapy market is projected to reach USD 62.3 billion by 2032, expanding at a compound annual growth rate (CAGR) of 6.1% over the forecast period.
- Disease Prevalence: In the United States alone, 12 million individuals are affected by COPD, with approximately 120,000 deaths reported annually. Globally, an estimated 334 million people suffer from asthma, highlighting the growing demand for oxygen therapy.
- Product Segmentation: The market is segmented into oxygen source equipment and oxygen delivery devices, with oxygen source equipment accounting for over 70% of revenue. This category includes oxygen concentrators, cylinders, and liquid oxygen systems.
- Device Trends: Portable oxygen devices dominate the market with 63.1% share, supported by technological advancements, the increasing mobility needs of patients, and the aging population.
- Applications: COPD represents the largest application segment, holding 34.6% market share, as the disease affects nearly 65 million people worldwide.
- End Users: Home healthcare leads with 58.5% share, driven by the adoption of Long-Term Oxygen Therapy (LTOT) devices that offer portability and ease of use.
- Regional Insights: North America dominated the market in 2022, supported by investments in research and rising demand for hyperbaric and topical oxygen therapies. The Asia-Pacific region is expected to witness the highest growth, driven by increasing healthcare expenditure and expanding patient populations.
Regional Analysis
In 2022, North America accounted for the largest revenue share of over 32.0%, primarily due to significant investments in research and development as well as ongoing clinical trials related to oxygen therapy. The growing demand for hyperbaric and topical oxygen therapies is further supporting market expansion in the region. In addition, factors such as urbanization and increasing occupational risks are expected to heighten the incidence of respiratory disorders, thereby driving the demand for oxygen therapy solutions.
The Asia Pacific market is projected to record the fastest CAGR in the coming years, supported by heavy R&D investments from global players and the rising commercialization of advanced oxygen therapy equipment. The region is also witnessing strong demand for new systems, along with substantial efforts to replace and modernize existing healthcare infrastructure.
These developments are expected to create lucrative opportunities for market growth. Moreover, technological advancements and the expansion of distribution networks by leading global companies are anticipated to accelerate adoption and strengthen the regional market outlook.
Frequently Asked Questions on Oxygen Therapy
- What is oxygen therapy?
-Oxygen therapy is a medical treatment that delivers supplemental oxygen to individuals with breathing difficulties or low oxygen levels. It is commonly used for patients with chronic respiratory conditions like COPD, asthma, and sleep apnea. - Who needs oxygen therapy?
-Oxygen therapy is recommended for patients whose blood oxygen levels fall below normal, particularly those suffering from COPD, pneumonia, asthma, heart failure, or sleep apnea. It helps maintain adequate oxygen saturation, improving overall health and quality of life. - What types of oxygen therapy devices are available?
-Oxygen therapy devices include oxygen concentrators, liquid oxygen systems, and compressed gas cylinders. Delivery devices such as nasal cannulas, masks, and portable systems are widely used depending on patient requirements, convenience, and healthcare provider recommendations. - Are portable oxygen devices effective?
-Yes, portable oxygen devices are highly effective and increasingly popular. They provide mobility, independence, and convenience for patients, allowing them to manage respiratory conditions while maintaining active lifestyles. Technological innovations have significantly improved their performance and reliability. - What are the risks of oxygen therapy?
-While oxygen therapy is generally safe, excessive or improper use can cause oxygen toxicity, dryness in airways, and fire hazards. Therefore, usage must be guided by medical professionals, with proper equipment handling and adherence to safety protocols. - Which product segment dominates the oxygen therapy market?
-Oxygen source equipment, including concentrators, cylinders, and liquid oxygen systems, accounts for over 70% of revenue. Portable oxygen devices are leading within this category, driven by patient demand for mobility and convenience, especially among the aging population. - What are the main applications of oxygen therapy?
-Oxygen therapy is primarily applied in treating COPD, asthma, sleep apnea, and respiratory distress. COPD holds the largest share at 34.6%, as the disease affects around 65 million people worldwide, creating sustained demand for oxygen solutions. - Which region leads the oxygen therapy market?
-North America dominates the market with over 32% share, owing to strong R\&D investments, rising prevalence of respiratory diseases, and high adoption of hyperbaric and topical oxygen therapies. The Asia-Pacific region is expected to witness the fastest growth. - Who are the major end-users of oxygen therapy devices?
-Home healthcare is the leading end-user segment, accounting for 58.5% market share. The demand is fueled by long-term oxygen therapy (LTOT) devices that offer ease of use, portability, and cost-effectiveness compared to hospital-based treatments.
Conclusion
The global oxygen therapy market is positioned for sustained expansion, driven by rising respiratory disease prevalence, technological innovation, and increasing healthcare investments. With COPD, asthma, and sleep apnea continuing to affect millions worldwide, demand for advanced oxygen therapy solutions is accelerating.
Portable and home-based devices are reshaping patient care by improving accessibility, mobility, and cost efficiency. North America currently leads due to strong research activity, while Asia Pacific is emerging as the fastest-growing region. Supported by government initiatives, modernization of healthcare infrastructure, and industry innovation, the oxygen therapy market is expected to achieve robust long-term growth.
Discuss your needs with our analyst
Please share your requirements with more details so our analyst can check if they can solve your problem(s)
